Correlation Between PACS Group, and Tandem Diabetes

Can any of the company-specific risk be diversified away by investing in both PACS Group, and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PACS Group, and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PACS Group, and Tandem Diabetes Care, you can compare the effects of market volatilities on PACS Group, and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PACS Group, with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of PACS Group, and Tandem Diabetes.

Diversification Opportunities for PACS Group, and Tandem Diabetes

-0.07

Correlation Coefficient

PACS Group,  Tandem Diabetes

Good diversification

The 3 months correlation between PACS and Tandem is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding PACS Group, and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and PACS Group, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PACS Group, are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of PACS Group, i.e., PACS Group, and Tandem Diabetes go up and down completely randomly.

Pair Corralation between PACS Group, and Tandem Diabetes

Given the investment horizon of 90 days PACS Group, is expected to generate 0.74 times more return on investment than Tandem Diabetes. However, PACS Group, is 1.35 times less risky than Tandem Diabetes. It trades about 0.18 of its potential returns per unit of risk. Tandem Diabetes Care is currently generating about -0.08 per unit of risk. If you would invest  1,308  in PACS Group, on October 22, 2024 and sell it today you would earn a total of  74.00  from holding PACS Group, or generate 5.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

PACS Group,  vs.  Tandem Diabetes Care

PACS Group,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PACS Group, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Tandem Diabetes Care

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Tandem Diabetes Care are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Tandem Diabetes may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with PACS Group, and Tandem Diabetes

The main advantage of trading using opposite PACS Group, and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PACS Group, position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.

The idea behind PACS Group, and Tandem Diabetes Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.